Review article · 14 Sep 2022
Conference abstractPublished 6 Jan 2014
Obesity- The big problem
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Obesity is from the Latin obesitas, which means "stout, fat, or plump". Medically, obesity is known as a condition in which excess body fat has accumulated to the extent that it may have an adverse effect on health, leading to reduced life expectancy and/or increased health problems. People are considered obese when the body mass index (BMI) exceeds 30 kg/m 2 . It has become a global epidemic affecting approximately 1.5 billion adults, and costing 150 billion dollars of health economy. It is a more common and rapidly growing problem in the United States of America (USA); the average weight of an adult worldwide is 62 kg while in the USA it is 80 kg. Though increased calorie intake, and sedentary life style has been majorly attributed to explain most cases of obesity, the other factors that should be considered in the differential include endocrine disorders, psychiatric illness, medications, genetics, and infectious agents. The United States Preventive Services Task Force recommends screening for all adults followed by behavioral interventions (Grade B recommendation) in those who are obese. It is considered important to intervene because obesity is one of the leading preventable causes of death worldwide. On average, obesity reduces life expectancy by six to seven years, a BMI of 30?35 kg/m 2 reduces life expectancy by two to four years, while severe obesity (BMI > 40 kg/m 2 ) reduces life expectancy by ten years. Public health efforts seek to understand and correct the environmental factors responsible for the increasing prevalence of obesity in the population. The main treatment for obesity consists of dieting and physical exercise. Ideal initial plan should be to lose 5-10% of body weight (1-2 lb per week) using combination of diet, physical activity, and behavioral techniques which include but not limited to self control, weight tracking, stimulus control, and group support. In case of failure to lose weight with following the above plan for at least six months, medical management is indicated for BMI>30 kg/m 2 or 27 kg/m 2 plus comorbidities. Drugs FDA approved for weight loss are Orlistat (Xenical), Locaserine (Belviq) and a combination of Phentermine and topiramate (Qsymia); Sibutramine is recently withdrawn due to cardiovascular side effects. The most effective treatment for obesity is bariatric surgery. However, due to its cost and the risk of complications, it is currently indicated for the patients with BMI >40 kg/m 2 or 35 kg/m 2 plus comorbidities. In summary, obesity management includes early intervention with dietary restrictions, and regular exercise; medical and surgical interventions with long term follow up are appropriate in certain BMI cohorts and/or when the prior management plan fails.
Subjects
Obesity & Weight ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 3 Feb 2022
Is there an endogeneity problem between health and apartment value? Gender differences and the impact of obesity on property self-evaluation
Conference abstract · 23 Sep 2021
No easy solution for a complex problem- Maintaining healty body weight and preventing overweight and obesity
Perspective · 5 Aug 2021
Obesity is linked to Heavy Periods and Womb Repair Problems: A Study
Editorial · 25 Nov 2020
Obesity as a Mental Problem
More from this journal
The newest in Journal of Obesity & Weight Loss Therapy.
Mini review · 13 Apr 2026
Semaglutide in the Real World: Bridging Effectiveness and Clinical Feasibility Through Flexible Dose Titration
Research article · 27 Feb 2026
Modulation of Postprandial GLP-1 Secretion and Glycemic Responses by a Food-Grade GLP-1 Formula in Human Subjects
Short communication · 9 Feb 2026
Intensive Blood Pressure Lowering Target Guided by Home Blood Pressure Monitoring for Hypertensive Patients with Type 2 Diabetes, Which is Better or Not
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Obesity & Weight Loss Therapy
- SubjectObesity & Weight Management
- BylineArticles whose byline prints “Bhanu K. Patibandla”
